Skip to Main Content

Author Details

Robyn Reynolds
Tufts University School of Medicine and Tufts Medical Center
2006
34
29
PMIDPaper TitleJournal TitlePublished Year
24498017Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration.PLoS One2014
25033836(Epi)Genetic analyses of age-related macular degeneration: case-control and discordant twin studies.Hum Hered2014
24847005Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration.Hum Mol Genet2014
23481534Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy.Ophthalmology2013
24036952Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration.Nat Genet2013
23411794Validation of a prediction algorithm for progression to advanced macular degeneration subtypes.JAMA Ophthalmol2013
23455636Seven new loci associated with age-related macular degeneration.Nat Genet2013
22247473Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.Invest Ophthalmol Vis Sci2012
22705344Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.Ophthalmology2012
22678500Genetic factors for choroidal neovascularization associated with high myopia.Invest Ophthalmol Vis Sci2012
21122828ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration.Am J Ophthalmol2011
22019782A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.Nat Genet2011
22039249Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration.Invest Ophthalmol Vis Sci2011
21959373Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.Ophthalmology2011
21620475Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications.Ophthalmology2011
21665990Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.Hum Mol Genet2011
21339308Kidney function, albuminuria and age-related macular degeneration in NHANES III.Nephrol Dial Transplant2011
21447678Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.Invest Ophthalmol Vis Sci2011
19844262Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach.Eur J Hum Genet2010
21139980Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration.Mol Vis2010
20888482Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.Ophthalmology2010
20581873Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.Nat Genet2010
20385826Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).Proc Natl Acad Sci U S A2010
20385819Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.Proc Natl Acad Sci U S A2010
18685559Variation near complement factor I is associated with risk of advanced AMD.Eur J Hum Genet2009
19661236Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.Invest Ophthalmol Vis Sci2009
19806217rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration.PLoS One2009
19117936Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.Invest Ophthalmol Vis Sci2009
18936151Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.Invest Ophthalmol Vis Sci2009
18423869CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.Ophthalmology2008
18261073Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.Int J Clin Pract2008
17767156Variation in complement factor 3 is associated with risk of age-related macular degeneration.Nat Genet2007
16432273Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate.J Clin Pharmacol2006
16513448Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir.Clin Pharmacol Ther2006
  • 1 - 34 of 34

Recommended Authors

Moorfields Eye Hospital, UK UCL Institute of Ophthalmology, University College London
Career Start Year 2014
Number of shared co-authors 11
National Eye Institute, National Institutes of Health.
Career Start Year 2013
Number of shared co-authors 13
Institute for Vision Research, Carver College of Medicine, University of Iowa
Career Start Year 2012
Number of shared co-authors 3
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 6
Karolinska Institutet
Career Start Year 2011
Number of shared co-authors 41
Vanderbilt Eye Institute, Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 2
University of Tennessee College of Medicine Chattanooga
Career Start Year 2008
Number of shared co-authors 18
University of Kentucky
Career Start Year 2007
Number of shared co-authors 6
National Eye Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 12
University of Yamanashi
Career Start Year 2004
Number of shared co-authors 3
Westmead Clinical School, University of Sydney
Career Start Year 2004
Number of shared co-authors 42
Division of Epidemiology and Clinical Applications, National Eye Institute
Career Start Year 2003
Number of shared co-authors 15
Duke University Medical Center
Career Start Year 2002
Number of shared co-authors 8
Menzies Institute for Medical Research, University of Tasmania
Career Start Year 2001
Number of shared co-authors 53
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 53
Unit on Clinical Investigation of Retinal Disease, National Eye Institute
Career Start Year 2000
Number of shared co-authors 10
Shiley Eye Institute, University of California San Diego
Career Start Year 1999
Number of shared co-authors 8
The EMMES Corporation
Career Start Year 1999
Number of shared co-authors 14
Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 13
University of Minnesota Medical School, 1035 University Drive duluth
Career Start Year 1996
Number of shared co-authors 17
University of California San Diego
Career Start Year 1995
Number of shared co-authors 38
Shiley Eye Institute, University of California San Diego
Career Start Year 1993
Number of shared co-authors 17
the University of Iowa Carver College of Medicine
Career Start Year 1993
Number of shared co-authors 15
Flinders Medical Centre, Flinders University
Career Start Year 1992
Number of shared co-authors 51
National Eye Institute, National Institute of Health
Career Start Year 1990
Number of shared co-authors 22
Radboud University Medical Center
Career Start Year 1989
Number of shared co-authors 56
Lions Eye Institute, University of Western Australia
Career Start Year 1989
Number of shared co-authors 54
Harvard Medical School, Harvard University
Career Start Year 1987
Number of shared co-authors 33
Wills Eye Hospital, Sidney Kimmel Medical Center at Thomas Jefferson University
Career Start Year 1983
Number of shared co-authors 9
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1979
Number of shared co-authors 9

Collaborators

University of Massachusetts Chan Medical School
Co-authored papers 31
Massachusetts General Hospital
Co-authored papers 17
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 14
Tufts Medical Center
Co-authored papers 13
Center for Human Genetic Research, Massachusetts General Hospital
Co-authored papers 13
University of Paris Est-Creteil
Co-authored papers 8
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 7
Massachusetts Eye and Ear Infirmary
Co-authored papers 7
Northwestern University
Co-authored papers 7
Center for Human Disease Modeling, Duke University School of Medicine
Co-authored papers 6
Johns Hopkins University School of Medicine
Co-authored papers 6
The Wilmer Eye Institute, Johns Hopkins University School of Medicine
Co-authored papers 6
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 6
Universite de Poitiers, INSERM 4 Department of Ophthalmology
Co-authored papers 5
Massachusetts General Hospital
Co-authored papers 5
Boston Children's Hospital
Co-authored papers 4
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Co-authored papers 4
& Throat Hospital
Co-authored papers 4
Columbia University Medical Center
Co-authored papers 4
Mount Sinai School of Medicine
Co-authored papers 4
Columbia University
Co-authored papers 4
The University of Melbourne
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3
Erasmus Medical Center
Co-authored papers 3
Regeneron Pharmaceuticals Inc.
Co-authored papers 3
University of Oxford
Co-authored papers 3
Johns Hopkins School of Medicine
Co-authored papers 3
Erasmus Medical Center
Co-authored papers 3
National Eye Institute, National Institutes of Health
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3